Skip to main content

Advertisement

Log in

Brain metastasis: clinical characteristics, pathological findings and molecular subtyping for therapeutic implications

  • Review Article
  • Published:
Brain Tumor Pathology Aims and scope Submit manuscript

Abstract

Metastases are the most common brain tumors especially in adults. Although they are generally considered a single disease entity which is universally fatal in patients with advanced cancer, brain metastases are remarkably heterogeneous both clinically and pathologically. As members of the multidisciplinary clinical team for the diagnosis and management of metastatic brain tumors, pathologists must be familiar not only with clinicopathologic features of brain metastases but also with any characteristic and clinically significant molecular findings. We discuss here the epidemiology, general gross and microscopic features of brain metastases with emphasis on how to differentiate them from primary brain tumors using immunohistochemistry (e.g., for identification of the primary site and differential diagnosis), and unique pathologic patterns of brain metastases (namely, dural metastasis, leptomeningeal carcinomatosis, miliary metastasis, “intravascular carcinomatosis”, and tumor-to-tumor metastasis) with their clinical and radiological characteristics. We specifically address metastatic breast and non-small cell lung cancers which are the two most commonly encountered in daily practice, with emphasis on the molecular alterations related to therapy and their clinicopathologic significance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Achal Singh Achrol, Robert C. Rennert, … Steven D. Chang

References

  1. Nayak L, Lee EQ, Wen PY (2012) Epidemiology of brain metastases. Curr Oncol Rep 14:48–54

    Article  PubMed  Google Scholar 

  2. Iuchi T, Shingyoji M, Itakura M et al (2014) Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations. Int J Clin Oncol 20:674–679

    Article  PubMed  Google Scholar 

  3. Berghoff AS, Bago-Horvath Z et al (2013) Impact of Her-2-targeted therapy n overall survival in patients with Her-2 positive metastatic breast cancer. Breast J 19:149–155

    Article  PubMed  CAS  Google Scholar 

  4. Dummer R, Goldinger SM, Turtschi CP et al (2014) Vemurafenib in patients with BRAF V600 mutation-positive melanoma with symptomatic brain metastases: final results of an open-label pilot study. Eur J Cancer 50:611–621

    Article  PubMed  CAS  Google Scholar 

  5. Beierwaltes WH, Lieberman LM, Varma VM, Counsell RE (1968) Visualizing human malignant melanoma and metastases. Use of chloroquine analog tagged with iodine 125. JAMA 206:97–102

    Article  PubMed  CAS  Google Scholar 

  6. DeAngelis LM (1994) Management of brain metastases. Cancer Invest 12:156–165

    Article  PubMed  CAS  Google Scholar 

  7. Nussbaum ES, Djalilian HR, Cho KH, Hall WA (1996) Brain metastases. Histology, multiplicity, surgery, and survival. Cancer 78:1781–1788

    Article  PubMed  CAS  Google Scholar 

  8. Lagerwaard FJ, Levendag PC, Nowak PJ et al (1999) Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. Int J Radiat Oncol Biol Phys 43:795–803

    Article  PubMed  CAS  Google Scholar 

  9. Long GV, Menzies AM, Nagrial AM et al (2011) Prognostic and clinicopathologic associations of oncogenic BRAF in metastatic melanoma. J Clin Oncol 29:1239–1246

    Article  PubMed  Google Scholar 

  10. Skibber JM, Soong SJ, Austin L et al (1996) Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol 3:118–123

    Article  PubMed  CAS  Google Scholar 

  11. Kolomainen DF, Larkin JM, Badran M et al (2002) Epithelial ovarian cancer metastasizing to the brain: a late manifestation of the disease with an increasing incidence. J Clin Oncol 20:982–986

    Article  PubMed  Google Scholar 

  12. Tremont-Lukats IW, Bobustuc G, Lagos GK et al (2003) Brain metastasis from prostate carcinoma: the M. D. Anderson Cancer Center experience. Cancer 98:363–368

    Article  PubMed  Google Scholar 

  13. Hjiyiannakis P, Jefferies S, Harmer CL (1996) Brain metastases in patients with differentiated thyroid carcinoma. Clin Oncol (R. Coll Radiol) 8:327–330

    Article  CAS  Google Scholar 

  14. Fox BD, Patel A, Suki D, Rao G (2009) Surgical management of metastatic sarcoma to the brain. J Neurosurg 110:181–186

    Article  PubMed  Google Scholar 

  15. Kebudi R, Ayan I, Görgün O et al (2005) Brain metastasis in pediatric extracranial solid tumors: survey and literature review. J Neurooncol 71:43–48

    Article  PubMed  Google Scholar 

  16. Curless RG, Toledano SR, Ragheb J et al (2002) Hematogenous brain metastasis in children. Pediatr Neurol 26:219–221

    Article  PubMed  Google Scholar 

  17. Parker GD, Hamsberger HR (1991) Clinical-radiologic issues in perineural tumor spread of malignant diseases of the extracranial head and neck. Radiographics 11:383–399

    Article  PubMed  CAS  Google Scholar 

  18. Porter AT, David M (2007) Palliative care for bone, spinal cord, brain and liver metastases. In: Gunderson LL, Tepper JE (eds) Clinical radiation oncology. Elsevier, Philadelphia, pp 437–455

    Google Scholar 

  19. Narayana A, Liebel SA (2004) Primary and metastatic brain tumors. In: Liebel SA, Phillips TL (eds) Textbook of radiation oncology. Elsevier, Philadelphia, pp 463–495

    Google Scholar 

  20. Nonaka H, Akima M, Hatori T et al (2003) The microvascular of the cerebral white matter: arteries of the subcortical white matter. J Neuropathol Exp Neurol 62:154–161

    PubMed  Google Scholar 

  21. Hwang TL, Close TP, Grego JM et al (1996) Predilection of brain metastasis in gray and white matter junction and vascular border zones. Cancer 77:1551–1555

    Article  PubMed  CAS  Google Scholar 

  22. Fowler BZ, Crocker IR, Johnstone PAS (2005) Perineural spread of cutaneous malignancy to the brain. A review of the literature and five patients treated with stereotactic radiotherapy. Cancer 103:2143–2153

    Article  PubMed  Google Scholar 

  23. Pekmezci M, Perry A (2013) Neuropathology of brain metastasis. Surg Neurol Int 4(Suppl 4):S245–S255

    PubMed  PubMed Central  Google Scholar 

  24. Tacha D, Qi W, Ra S et al (2015) A newly developed mouse monoclonal SOX10 antibody is a highly sensitive and specific marker for malignant melanoma, including spindle cell and desmoplastic melanomas. Arch Pathol Lab Med 139:530–536

    Article  PubMed  Google Scholar 

  25. Carney EM, Banerjee P, Ellis CL et al (2011) PAX2(−)/PAX8(−)/inhibin A(+) immunoprofile in hemangioblastoma: a helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system. Am J Surg Pathol 35:362–367

    Google Scholar 

  26. Kawakami F, Takei H (2015) Central nervous system metastasis. In: Rivera A, Takei H (eds) Advances in surgical pathology. Brain cancer. Wolter Kluwer, Philadelphia, pp 189–196

    Google Scholar 

  27. Posner JB, Chernik NL (1978) Intracranial metastases from systemic cancer. In: Schoenberg BS (ed) Advances in neurology. Raven Press, New York, pp 579–592

    Google Scholar 

  28. Takakura K, Sano K, Hojo S, Hirano A (1982) Metastatic tumors of the central nervous system. Igaku-shoin, Tokyo

    Google Scholar 

  29. Nayak L, Abrey LE, Iwamoto FM (2009) Intracranial dural metastases. Cancer 115:1947–1953

    Article  PubMed  Google Scholar 

  30. Laigle-Donadey F, Taillibert S, Mokhtari K et al (2005) Dural metastases. J Neurooncol 75:57–61

    Article  PubMed  Google Scholar 

  31. Caputi F, Lamaida E, Gazzeri R (1999) Acute subdural hematoma and pachymeningitis carcinomatosa: case report. Rev Neurol (Paris) 155:383–385

    CAS  Google Scholar 

  32. Turner DM, Graf CJ (1982) Nontraumatic subdural hematoma secondary to dural metastasis: case report and review of the literature. Neurosurgery 11:678–680

    Article  PubMed  CAS  Google Scholar 

  33. Bucci MN, Farhat SM (1986) Metastatic adenocarcinoma of the prostate as a cause of subdural hematoma. J Urol 135:803–804

    PubMed  CAS  Google Scholar 

  34. Russell DS, Cairns H (1934) Subdural false membrane or haematoma (pachymeningitis interna haemorrhagica) in carcinomatosis and sarcomatosis of the dura mater. Brain 57:32–48

    Article  Google Scholar 

  35. Pace A, Fabi A (2006) Chemotherapy in neoplastic meningitis. Crit Rev Oncol Hematol 60:194–200

    Article  PubMed  Google Scholar 

  36. Chowdhary S, Chamberlain M (2005) Leptomeningeal metastases: current concepts and management guidelines. J Natl Compr Cancer Netw 3:693–703

    Google Scholar 

  37. Glass JP, Melamed M, Chernik NL, Posner JB (1979) Malignant cells in cerebrospinal fluid (CSF): the meaning of a positive CSF cytology. Neurology 29:1369–1375

    Article  PubMed  CAS  Google Scholar 

  38. Jaeckle KA (2006) Neoplastic meningitis from systemic malignancies: diagnosis, prognosis and treatment. Semin Oncol 33:312–323

    Article  PubMed  Google Scholar 

  39. Wasserstrom WR, Glass JP, Posner JB (1982) Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer 49:759–772

    Article  PubMed  CAS  Google Scholar 

  40. Kaplan JG, DeSouza TG, Farkash A et al (1990) Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias. J Neurooncol 9:225–229

    Article  PubMed  CAS  Google Scholar 

  41. Amer MH, Al-Sarraf M, Baker LH, Valtkevicius VK (1978) Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer 42:660–668

    Article  PubMed  CAS  Google Scholar 

  42. Niwińska A, Rudnicka H, Murawska M (2013) Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival. Med Oncol 30:408

    Article  PubMed  PubMed Central  Google Scholar 

  43. Yap HY, Yap BS, Tashima CK, DiStefano A, Blumenschein GR (1978) Meningeal carcinomatosis in breast cancer. Cancer 42:283–286

    Article  PubMed  CAS  Google Scholar 

  44. Chamberlain MC (2005) Neoplastic meningitis. J Clin Oncol 23:3605–3613

    Article  PubMed  Google Scholar 

  45. Subira D, Simo M, Illan J et al (2015) Diagnostic and prognostic significance of flow cytometry immunophenotyping in patients with leptomeningeal carcinomatosis. Clin Exp Metastasis 32:383–391

    Article  PubMed  CAS  Google Scholar 

  46. Garson JA, Coakham HB, Kemshead JT et al (1985) The role of monoclonal antibodies in brain tumour diagnosis and cerebrospinal fluid (CSF) cytology. J Neurooncol 3:165–171

    Article  PubMed  CAS  Google Scholar 

  47. Hovestadt A, Henzen-Logmans SC, Vecht CJ (1990) Immunohistochemical analysis of the cerebrospinal fluid for carcinomatous and lymphomatous leptomeningitis. Br J Cancer 62:653–654

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  48. Boogerd W, Vroom TM, van Heerde P et al (1988) CSF cytology versus immunohistochemistry in meningeal carcinomatosis. J Neurol Neurosurg Psychiatry 51:142–145

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  49. Madow L, Alpers BJ (1951) Encephalitic form of metastatic carcinoma. AMA Arch Neurol Psychiatry 65:161–173

    Article  PubMed  CAS  Google Scholar 

  50. Ogawa M, Kurahishi K, Ebina A et al (2007) Miliary brain metastasis presenting with dementia: progression pattern of cancer metastases in the cerebral cortex. Neuropathology 27:390–395

    Article  PubMed  Google Scholar 

  51. Iguchi Y, Mano K, Goto Y et al (2007) Miliary brain metastases from adenocarcinoma of the lung: MR imaging findings with clinical and post-mortem histopathologic correlation. Neuroradiology 49:35–39

    Article  PubMed  Google Scholar 

  52. Kahveci R, Gurer B, Kaygusuz G, Sekerci Z (2012) Miliary brain metastases from occult lung adenocarcinoma: radiologic and histopathologic confirmation. J Neurosci Rural Pract 3:386–389

    Article  PubMed  PubMed Central  Google Scholar 

  53. Hutchings M, Weller RO (1986) Anatomical relationships of the pia mater to cerebral blood vessels in man. J Neurosurg 65:316–325

    Article  PubMed  CAS  Google Scholar 

  54. Zhang ET, Inman CBE, Weller RO (1990) Interrelationships of the pia mater and the perivascular (Virchow–Robin) spaces in the human cerebrum. J Anat 170:111–123

    PubMed  CAS  PubMed Central  Google Scholar 

  55. Takei H, Rouah E, Barrios R (2015) Intravascular carcinomatosis of central nervous system due to metastatic inflammatory breast cancer: a case report. Neuropathology 35:456–461

    Article  PubMed  Google Scholar 

  56. Campbell LV, Gilbert E, Chamberlein CR, Watne AL (1968) Metastases of cancer to cancer. Cancer 22:635–643

    Article  PubMed  Google Scholar 

  57. Pamphlett R (1984) Carcinoma metastasis to meningioma. J Neurol Neurosurg Psychiatry 47:561–563

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  58. Erdogan H, Aydin MV, Tasdemiroglu E (2014) Tumor-to-tumor metastasis of the central nervous system. Turk Neurosurg 24:151–162

    PubMed  Google Scholar 

  59. Hamazaki S, Nakashima H, Matsumoto K et al (2001) Metastasis of renal cell carcinoma to central nervous system hemangioblastoma in two patients with von Hippel-Lindau disease. Pathol Int 51:948–953

    Article  PubMed  CAS  Google Scholar 

  60. Mottolese C, Stan H, Giordano F et al (2001) Metastasis of clear-cell renal carcinoma to cerebellar hemangioblastoma in von Hippel-Lindau disease: rare or not investigated. Acta Neurochir (Wien) 143:1059–1063

    Article  CAS  Google Scholar 

  61. Chambers PW, Davis RL, Blanding JD, Buck FS (1980) Metastases to primary intracranial meningiomas and neurilemmomas. Arch Pathol Lab Med 104:350–354

    PubMed  CAS  Google Scholar 

  62. Li Z, Lu J, Zhao Y, Guo H (2011) The retrospective analysis of the frequency of EGFR mutations and efficacy of gefitinib in NSCLC patients with brain metastases. J Clin Oncol 29:e18065

    Google Scholar 

  63. Rangachari D, Yamaguchi N, VanderLaan PA et al (2015) Brain metastases in patients with EGFR-mutated or ALK-rearranged non-small-cell lung cancers. Lung Cancer 88:108–111

    Article  PubMed  Google Scholar 

  64. Zhang J, Yu J, Sun X, Meng X (2014) Epidermal growth factor receptor tyrosine kinase inhibitors in the treatment of central nerve system metastases from non-small cell lung cancer. Cancer Lett 351:6–12

    Article  PubMed  CAS  Google Scholar 

  65. Camidge DR, Bang YJ, Kwak EL (2012) Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase I study. Lancet Oncol 13:1011–1019

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  66. Otterson GA, Riely GJ, Shaw AT (2012) Clinical characteristics of ALK + NSCLC patients treated with crizotinib beyond disease progression: potential implications for management. Proc Am Soc Clin Oncol 30(Suppl):abstract 7600

  67. Guerin A, Sasane M, Zhang J et al (2015) Brain metastasis in patients with ALK+ non-small cell lung cancer: clinical symptoms, treatment patterns and economic burden. J Med Econ 18:321–322

    Google Scholar 

  68. Gainor JF, Ignatius S-H, Logan J, Borges LF, Shaw AT (2013) The central nervous system as a sanctuary site in ALK-positive non-small cell lung cancer. J Thorac Oncol 8:1570–1573

    Article  PubMed  CAS  Google Scholar 

  69. Weil RJ, Palmieri DC, Bronder JL, Stark AM, Steeg PS (2005) Breast cancer metastasis to the central nervous system. Am J Pathol 167:913–920

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  70. Kennecke H, Yerushalmi R, Woods R et al (2012) Metastatic behavior of breast cancer subtype. J Clin Oncol 28:3271–3277

    Article  Google Scholar 

  71. Gil-Gil MJ, Martinez-Garcia M, Sierra A et al (2014) Breast cancer brain metastases: a review of the literature and a current multidisciplinary management guideline. Clin Transl Oncol 16:436–446

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  72. Shen Q, Sahin AA, Hess KR et al (2015) Breast cancer with brain metastases: clinicopathologic features, survival, and paired biomarker analysis. Oncologist 20:466–473

    Article  PubMed  Google Scholar 

  73. Van Poznak C, Somerfield MR, Bast RC et al (2015) Use of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 33:2695–2704

    Article  PubMed  Google Scholar 

  74. Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast. CAP www.cap.org/apps/docs/committees/…/her2_faqs.pdf. Accessed 25 Aug 2015

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hidehiro Takei.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Takei, H., Rouah, E. & Ishida, Y. Brain metastasis: clinical characteristics, pathological findings and molecular subtyping for therapeutic implications. Brain Tumor Pathol 33, 1–12 (2016). https://doi.org/10.1007/s10014-015-0235-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10014-015-0235-3

Keywords

Navigation